In: Plos pathogens, 2013, vol. 9, no. 2, p. e1003157
Dengue hemorrhagic fever and dengue shock syndrome (DHF/DSS) are life-threatening complications following infection with one of the four serotypes of dengue virus (DENV). At present, no vaccine or antiviral therapies are available against dengue. Here, we characterized a panel of eight human or mouse-human chimeric monoclonal antibodies (MAbs) and their modified variants lacking effector...
|
In: Breast Cancer Research and Treatment, 2014, vol. 147, no. 2, p. 459-462
|
In: Clinical & Experimental Metastasis, 2009, vol. 26, no. 7, p. 809-815
|
In: Targeted Oncology, 2010, vol. 5, no. 3, p. 201-210
|
In: Graefe's Archive for Clinical and Experimental Ophthalmology, 2005, vol. 243, no. 2, p. 156-162
|
In: Journal of Neuro-Oncology, 2011, vol. 103, no. 3, p. 417-427
|
In: European Journal of Nuclear Medicine and Molecular Imaging, 2009, vol. 36, no. 9, p. 1443-1452
|
In: Virchows Archiv, 2008, vol. 452, no. 6, p. 637-650
|
In: Cancer Immunology, Immunotherapy, 2007, vol. 56, no. 11, p. 1723-1731
|
In: Analytical and Bioanalytical Chemistry, 2013, vol. 405, no. 10, p. 3137-3151
|